| Dr Emily Dorothea Helmrich, DO | |
|
Msc07-4040 1 University Of New Mexico, Albuquerque, NM 87131 | |
| (505) 272-3053 | |
| (505) 925-0546 |
| Full Name | Dr Emily Dorothea Helmrich |
|---|---|
| Gender | Female |
| Speciality | Pathology - Forensic Pathology |
| Location | Msc07-4040 1 University Of New Mexico, Albuquerque, New Mexico |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265886576 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZF0201X | Pathology - Forensic Pathology | A-2298-19 (New Mexico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Emily Dorothea Helmrich, DO Msc07-4040 1 University Of New Mexico, Albuquerque, NM 87131 Ph: () - | Dr Emily Dorothea Helmrich, DO Msc07-4040 1 University Of New Mexico, Albuquerque, NM 87131 Ph: (505) 272-3053 |
News Archive
National Jewish Health researchers and their colleagues in the COPDGene research consortium report that a computerized form of radiology, known as quantitative CT, can offer valuable prognostic information for patients and doctors beyond the standard breathing tests most commonly used to evaluate chronic obstructive pulmonary disease.
The University of Miami Miller School of Medicine will soon begin one of the nation's first full-scale Zika vaccine clinical trials testing the National Institutes of Health's (NIH) experimental DNA-based vaccine.
Mater and University of Queensland Researcher Dr Mitchell Sullivan has been awarded a 2020 Advance Queensland Industry Research Fellowship from the Queensland Government to fund his research into diabetic kidney disease and COVID-19.
As part of an international research project, a team of researchers has developed a DNA clamp that can detect mutations at the DNA level with greater efficiency than methods currently in use. Their work could facilitate rapid screening of those diseases that have a genetic basis, such as cancer, and provide new tools for more advanced nanotechnology. The results of this research is published this month in the journal ACS Nano.
NephRx Corporation today announced that the U.S. Food and Drug Administration has granted orphan drug designation to its lead product NX001 for the prevention of delayed graft function in renal transplant recipients. NX001 is a kidney growth factor peptide that has demonstrated good safety and promising efficacy in two animal models of acute renal failure.
› Verified 9 days ago
Glynnis Ingall, Pathology Medicare: Not Enrolled in Medicare Practice Location: 2211 Lomas Blvd Ne, Albuquerque, NM 87106 Phone: 505-272-2445 | |
Dr. Larry Wayne Massie, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 1501 San Pedro Dr Se, Albuquerque, NM 87108 Phone: 505-256-5770 Fax: 505-256-5439 | |
Jennifer L Wheeler Buenger, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: Msc 10 5590, 1 University Of New Mexico, Albuquerque, NM 87131 Phone: 505-272-3053 Fax: 505-925-0546 | |
Dr. Joseph Ross Griggs, D.O. Pathology Medicare: Accepting Medicare Assignments Practice Location: Msc 08 4640, 1 University Of New Mexico, Albuquerque, NM 87131 Phone: 505-272-4814 Fax: 505-272-8084 | |
Zoe Sarah Sundell, MD Pathology Medicare: Medicare Enrolled Practice Location: 1 University Of New Mexico, Albuquerque, NM 87131 Phone: 505-272-4814 | |
Anne Bracey, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: Unm Hospital Pathology, 2211 Lomas Blvd Ne, Albuquerque, NM 87131 Phone: 505-272-6225 | |
Dr. James Anthony Halfacre Jr., M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1100 Central Ave Se, Albuquerque, NM 87106 Phone: 505-841-1234 |